BE708269A - - Google Patents
Info
- Publication number
- BE708269A BE708269A BE708269DA BE708269A BE 708269 A BE708269 A BE 708269A BE 708269D A BE708269D A BE 708269DA BE 708269 A BE708269 A BE 708269A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- caffeine
- coffee
- composition
- methylxanthine
- Prior art date
Links
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 102
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 51
- 229960001948 caffeine Drugs 0.000 claims description 51
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 51
- 235000013353 coffee beverage Nutrition 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims description 14
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-Methylxanthine Natural products N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 claims description 12
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 10
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 10
- MVOYJPOZRLFTCP-UHFFFAOYSA-N 1-methyl-7H-xanthine Chemical compound O=C1N(C)C(=O)NC2=C1NC=N2 MVOYJPOZRLFTCP-UHFFFAOYSA-N 0.000 claims description 8
- GMSNIKWWOQHZGF-UHFFFAOYSA-N 3-methyl-9H-xanthine Chemical compound O=C1NC(=O)N(C)C2=C1N=CN2 GMSNIKWWOQHZGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 229940075420 xanthine Drugs 0.000 claims description 6
- 229960004559 theobromine Drugs 0.000 claims description 5
- 230000004936 stimulating effect Effects 0.000 claims description 4
- RTAPDZBZLSXHQQ-UHFFFAOYSA-N 8-methyl-3,7-dihydropurine-2,6-dione Chemical class N1C(=O)NC(=O)C2=C1N=C(C)N2 RTAPDZBZLSXHQQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 235000021539 instant coffee Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 12
- 230000000638 stimulation Effects 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 230000002843 anti-caffeine Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- QUNWUDVFRNGTCO-UHFFFAOYSA-N 1,7-dimethylxanthine Chemical compound N1C(=O)N(C)C(=O)C2=C1N=CN2C QUNWUDVFRNGTCO-UHFFFAOYSA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229960000278 theophylline Drugs 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MGUBQPRSQWCLCX-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C.CN1C(=O)NC(=O)C2=C1N=CN2C MGUBQPRSQWCLCX-UHFFFAOYSA-N 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/20—Reducing or removing alkaloid content; Preparations produced thereby; Extracts or infusions thereof
- A23F5/202—Reducing or removing alkaloid content; Preparations produced thereby; Extracts or infusions thereof by addition of alkaloid neutralising or complexing agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE708269 | 1967-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE708269A true BE708269A (de) | 1968-06-20 |
Family
ID=3852025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE708269D BE708269A (de) | 1967-12-20 | 1967-12-20 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE708269A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4329632A4 (de) * | 2021-04-29 | 2025-04-16 | Rarebird, Inc. | Zusammensetzungen und verfahren zu ihrer herstellung |
-
1967
- 1967-12-20 BE BE708269D patent/BE708269A/nl unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4329632A4 (de) * | 2021-04-29 | 2025-04-16 | Rarebird, Inc. | Zusammensetzungen und verfahren zu ihrer herstellung |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220296552A1 (en) | Compositions and methods for acutely raising nitic oxide levels | |
| Bracco et al. | Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women | |
| Greenberg et al. | Coffee, diabetes, and weight control | |
| Wendl et al. | Effect of decaffeination of coffee or tea on gastro‐oesophageal reflux | |
| Acheson et al. | Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals | |
| Bellet et al. | Effect of coffee ingestion on catecholamine release | |
| EP0480934B1 (de) | Pharmazeutische zusammensetzung zum abnehmen | |
| Dorfman et al. | Comparative stimulant and diuretic actions of caffeine and theobromine in man | |
| EP2627199B1 (de) | Kaffeeextrakte als inhaltsstoffe von nahrungsmitteln, arzneimitteln, kosmetika, nahrungsergänzungsmitteln und biologika. | |
| US20100166851A1 (en) | Composition having lipolytic activity, production method thereof and use of the composition | |
| HK1001821B (en) | A slimming pharmaceutical composition | |
| EP2941261B1 (de) | Synergistische curcuma- und cissuszusammensetzungen zur verbesserung der physischen leistungs- und energiestufen | |
| Frevel et al. | Production, composition and toxicology studies of Enzogenol® Pinus radiata bark extract | |
| PL185056B1 (pl) | Kompozycja do podawania doustnego | |
| JP7327737B2 (ja) | アンペロプシンを含有する血中尿酸値低減用組成物 | |
| Carlo Tenore et al. | Coffee and depression: a short review of literature | |
| KR20010005642A (ko) | 진해 조성물 | |
| US20120269913A1 (en) | Crude caffeine complex, improved food products using the crude caffeine complex, and methods of use thereof | |
| Maurer et al. | The non-essentiality of fluorine in nutrition | |
| KR101227758B1 (ko) | 폭쇄처리된 굴참나무 목재칩을 용매로 추출한 굴참나무 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 조성물 | |
| BE708269A (de) | ||
| JP5282202B2 (ja) | 抗ストレス剤または睡眠改善剤 | |
| EP0993251B1 (de) | Genussmittel-zuschlag | |
| JP3059795B2 (ja) | 精神安定用食品 | |
| Widodo et al. | The effect of high temperature roasted Coffea liberica on physiological and histological structure of mice’s kidney |